Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BBNX Beta Bionics	$9.56 -3.0%	$10.85	$8.80 ▼ $32.71	$426.89M	3.29	1.20 million shs	54,100 shs
DCTH Delcath Systems	$11.11 +0.4%	$9.93	$8.12 ▼ $18.23	$383.03M	0.54	427,913 shs	89,965 shs
KIDS OrthoPediatrics	$17.27 +0.5%	$16.78	$14.42 ▼ $23.70	$443.52M	0.99	163,682 shs	12,508 shs
NYXH Nyxoah	$3.12 -6.5%	$3.25	$2.76 ▼ $8.64	$120.74M	1.56	48,287 shs	10,944 shs

10 Best Stocks to Own in 2026

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Spring 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BBNX Beta Bionics	+2.07%	-4.28%	+11.17%	-33.36%	-28.57%
DCTH Delcath Systems	-3.66%	+2.41%	+10.16%	+9.50%	-25.47%
KIDS OrthoPediatrics	-3.54%	+9.59%	+7.58%	+0.59%	-22.05%
NYXH Nyxoah	+2.15%	+11.00%	+16.43%	-28.23%	-47.14%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BBNX Beta Bionics	$9.56 -3.0%	$10.85	$8.80 ▼ $32.71	$426.89M	3.29	1.20 million shs	54,100 shs
DCTH Delcath Systems	$11.11 +0.4%	$9.93	$8.12 ▼ $18.23	$383.03M	0.54	427,913 shs	89,965 shs
KIDS OrthoPediatrics	$17.27 +0.5%	$16.78	$14.42 ▼ $23.70	$443.52M	0.99	163,682 shs	12,508 shs
NYXH Nyxoah	$3.12 -6.5%	$3.25	$2.76 ▼ $8.64	$120.74M	1.56	48,287 shs	10,944 shs

10 Best Stocks to Own in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BBNX Beta Bionics	+2.07%	-4.28%	+11.17%	-33.36%	-28.57%
DCTH Delcath Systems	-3.66%	+2.41%	+10.16%	+9.50%	-25.47%
KIDS OrthoPediatrics	-3.54%	+9.59%	+7.58%	+0.59%	-22.05%
NYXH Nyxoah	+2.15%	+11.00%	+16.43%	-28.23%	-47.14%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BBNX Beta Bionics	2.67	Moderate Buy	$22.00	130.17% Upside
DCTH Delcath Systems	2.67	Moderate Buy	$22.50	102.59% Upside
KIDS OrthoPediatrics	2.82	Moderate Buy	$24.44	41.51% Upside
NYXH Nyxoah	2.25	Hold	$8.33	167.52% Upside

Current Analyst Ratings Breakdown

Latest NYXH, BBNX, KIDS, and DCTH Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/12/2026	NYXH Nyxoah	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$8.00 ➝ $5.00
5/1/2026	KIDS OrthoPediatrics	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$17.00
5/1/2026	KIDS OrthoPediatrics	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$24.00
4/24/2026	KIDS OrthoPediatrics	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$25.00
4/22/2026	NYXH Nyxoah	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
4/22/2026	BBNX Beta Bionics	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Outperform	$25.00 ➝ $24.00
4/22/2026	BBNX Beta Bionics	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$22.00 ➝ $20.00
4/21/2026	BBNX Beta Bionics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
4/21/2026	KIDS OrthoPediatrics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
4/15/2026	BBNX Beta Bionics	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$25.00 ➝ $18.00
4/10/2026	NYXH Nyxoah	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$10.00 ➝ $8.00

(Data available from 5/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BBNX Beta Bionics	$100.25M	4.25	N/A	N/A	$6.53 per share	1.46
DCTH Delcath Systems	$85.23M	4.50	$0.05 per share	219.61	$3.15 per share	3.53
KIDS OrthoPediatrics	$236.35M	1.88	$0.16 per share	107.11	$13.82 per share	1.25
NYXH Nyxoah	$11.33M	10.66	N/A	N/A	$1.43 per share	2.18

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BBNX Beta Bionics	-$73.20M	-$1.51	N/A	N/A	N/A	-60.27%	-23.00%	-20.55%	N/A
DCTH Delcath Systems	$2.70M	$0.01	1,109.60	111.06	N/A	0.62%	0.51%	0.46%	N/A
KIDS OrthoPediatrics	-$39.65M	-$1.68	N/A	N/A	N/A	-16.31%	-7.01%	-4.86%	N/A
NYXH Nyxoah	-$101.92M	-$2.68	N/A	N/A	N/A	-884.69%	-139.18%	-79.53%	5/12/2026 (Estimated)

Latest NYXH, BBNX, KIDS, and DCTH Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/12/2026	Q1 2026	NYXH Nyxoah	-$0.54	N/A	N/A	N/A	$7.05 million	N/A
5/7/2026	Q1 2026	DCTH Delcath Systems	-$0.0971	-$0.03	+$0.0671	-$0.03	$23.51 million	$24.99 million
4/30/2026	Q1 2026	KIDS OrthoPediatrics	-$0.4552	-$0.42	+$0.0352	-$0.45	$58.29 million	$59.36 million
4/21/2026	Q1 2026	BBNX Beta Bionics	-$0.53	-$0.49	+$0.04	-$0.49	N/A	$27.63 million
3/19/2026	Q4 2025	NYXH Nyxoah	-$0.65	-$0.68	-$0.03	-$0.69	$5.70 million	$6.62 million
2/26/2026	Q4 2025	DCTH Delcath Systems	-$0.06	-$0.05	+$0.01	-$0.05	$20.35 million	$20.73 million
2/26/2026	Q4 2025	KIDS OrthoPediatrics	-$0.37	-$0.26	+$0.11	-$0.43	$61.27 million	$61.61 million
2/17/2026	Q4 2025	BBNX Beta Bionics	-$0.42	-$0.30	+$0.12	-$0.30	N/A	$32.12 million
2/14/2026	Q4 2025	NYXH Nyxoah	N/A	-$0.69	N/A	-$0.69	N/A	$6.62 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BBNX Beta Bionics	N/A	N/A	N/A	N/A	N/A
DCTH Delcath Systems	N/A	N/A	N/A	N/A	N/A
KIDS OrthoPediatrics	N/A	N/A	N/A	N/A	N/A
NYXH Nyxoah	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BBNX Beta Bionics	N/A	10.69	9.67
DCTH Delcath Systems	N/A	11.24	10.33
KIDS OrthoPediatrics	0.29	5.21	2.37
NYXH Nyxoah	0.37	1.25	1.16

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BBNX Beta Bionics	N/A
DCTH Delcath Systems	61.12%
KIDS OrthoPediatrics	69.05%
NYXH Nyxoah	N/A

Insider Ownership

Company	Insider Ownership
BBNX Beta Bionics	5.30%
DCTH Delcath Systems	19.36%
KIDS OrthoPediatrics	31.80%
NYXH Nyxoah	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BBNX Beta Bionics	294	44.56 million	42.20 million	N/A
DCTH Delcath Systems	60	34.52 million	27.84 million	Optionable
KIDS OrthoPediatrics	200	25.68 million	17.52 million	Optionable
NYXH Nyxoah	110	38.76 million	N/A	Not Optionable

NYXH, BBNX, KIDS, and DCTH Headlines

Recent News About These Companies

Nyxoah SA (XBRU:NYXH) Q1 2026 Earnings Report Preview: What To Expect

May 11 at 1:31 PM | finance.yahoo.com

How The Nyxoah (ENXTBR:NYXH) Narrative Is Shifting With CMS Codes And Trimmed Targets

May 5, 2026 | finance.yahoo.com

Nyxoah (NYXH) Projected to Post Earnings on Tuesday

May 5, 2026 | marketbeat.com

Nyxoah SA (NYXH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

May 5, 2026 | zacks.com

Nyxoah to Participate in the Bank of America 2026 Healthcare Conference

April 30, 2026 | markets.businessinsider.com

Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026

April 28, 2026 | globenewswire.com

Nyxoah (NYXH) price target decreased by 12.79% to 9.82

April 16, 2026 | msn.com

Baird Lowers its Price Target on Nyxoah SA (NYXH) to $4.62 from $5.87

April 5, 2026 | finance.yahoo.com

Baird Lowers its Price Target on Nyxoah SA (NYXH) to $4.62 from $5.87

April 4, 2026 | insidermonkey.com

Nyxoah (NYXH) Gets a Buy from Cantor Fitzgerald

March 25, 2026 | theglobeandmail.com

Publication relating to transparency notifications

March 20, 2026 | globenewswire.com

Nyxoah SA (NYXH) Q4 2025 Earnings Call Highlights: U.S. Launch Success and Financial Challenges

March 20, 2026 | finance.yahoo.com

Nyxoah SA (NYXH) Q4 2025 Earnings Call Transcript

March 19, 2026 | seekingalpha.com

Nyxoah SA (NYXH) Reports Q4 Loss, Misses Revenue Estimates

March 19, 2026 | zacks.com

Nyxoah Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

March 19, 2026 | globenewswire.com

Earnings To Watch: Nyxoah SA (XBRU:NYXH) Reports Q4 2025 Result

March 18, 2026 | finance.yahoo.com

Publication relating to transparency notification

March 13, 2026 | globenewswire.com

Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference

March 11, 2026 | globenewswire.com

Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026

March 5, 2026 | globenewswire.com

Information on the total number of voting rights and shares

February 25, 2026 | globenewswire.com

How The Nyxoah (ENXTBR:NYXH) Story Is Shifting As Assumptions And Risks Are Reworked

February 23, 2026 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

NYXH, BBNX, KIDS, and DCTH Company Descriptions

Beta Bionics NASDAQ:BBNX

$9.56 -0.29 (-2.96%)

As of 11:06 AM Eastern

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

Delcath Systems NASDAQ:DCTH

$11.11 +0.05 (+0.42%)

As of 11:05 AM Eastern

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.

OrthoPediatrics NASDAQ:KIDS

$17.27 +0.09 (+0.55%)

As of 11:06 AM Eastern

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Nyxoah NASDAQ:NYXH

$3.12 -0.22 (-6.46%)

As of 11:04 AM Eastern

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NYXH, BBNX, KIDS, and DCTH Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NYXH, BBNX, KIDS, and DCTH Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NYXH, BBNX, KIDS, and DCTH Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

NYXH, BBNX, KIDS, and DCTH Company Descriptions

Beta Bionics NASDAQ:BBNX

Delcath Systems NASDAQ:DCTH

OrthoPediatrics NASDAQ:KIDS

Nyxoah NASDAQ:NYXH

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NYXH, BBNX, KIDS, and DCTH Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NYXH, BBNX, KIDS, and DCTH Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NYXH, BBNX, KIDS, and DCTH Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

NYXH, BBNX, KIDS, and DCTH Company Descriptions

Beta Bionics NASDAQ:BBNX

Delcath Systems NASDAQ:DCTH

OrthoPediatrics NASDAQ:KIDS

Nyxoah NASDAQ:NYXH

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools